{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:00:13Z","timestamp":1771912813985,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.neuroimage.2011.12.037","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T02:44:36Z","timestamp":1325213076000},"page":"363-370","source":"Crossref","is-referenced-by-count":88,"title":["PET radiotracers for molecular imaging in the brain: Past, present and future"],"prefix":"10.1016","volume":"61","author":[{"given":"Luc","family":"Zimmer","sequence":"first","affiliation":[]},{"given":"Andr\u00e9","family":"Luxen","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.neuroimage.2011.12.037_bb0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S1461145704004110","article-title":"Do we still believe in the dopamine hypothesis? New data bring new evidence","volume":"1","author":"Abi-Dargham","year":"2004","journal-title":"Int. J. Neuropsychopharmacol. Suppl."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0010","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/cr0782426","article-title":"Molecular imaging with PET","volume":"108","author":"Ametamey","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuropharm.2006.09.023","article-title":"[18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain","volume":"52","author":"Aznavour","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuroimage.2006.08.012","article-title":"A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment","volume":"33","author":"Aznavour","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tins.2005.01.002","article-title":"Why glucose transport in the brain matters for PET","volume":"28","author":"Barros","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2006.01.006","article-title":"Intraneuronal trafficking of G-protein-coupled receptors in vivo","volume":"29","author":"Bernard","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2010.07.024","article-title":"The pre-requisite of a second-generation glioma PET biomarker","volume":"298","author":"Borbely","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0040","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2967\/jnumed.110.074773","article-title":"Hybrid PET\/MRI of intracranial masses: initial experiences and comparison to PET\/CT","volume":"51","author":"Boss","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0520","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1073\/pnas.022438099","article-title":"Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model","volume":"99","author":"Bjorklund","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2003.tb07460.x","article-title":"PET studies on the function of dopamine in health and Parkinson's disease","volume":"991","author":"Brooks","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 4","key":"10.1016\/j.neuroimage.2011.12.037_bb0050","first-page":"8","article-title":"Dopaminergic action beyond its effects on motor function: imaging studies","volume":"253","author":"Brooks","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0055","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/3300","article-title":"Combined PET\/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease","volume":"4","author":"Brownell","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0060","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/ejoc.200800114","article-title":"Chemistry with [18F]fluoride ion","author":"Cai","year":"2008","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0070","first-page":"1968","article-title":"Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner","volume":"47","author":"Catana","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0075","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00259-008-0908-9","article-title":"Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers","volume":"35","author":"Chauveau","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drudis.2008.12.006","article-title":"Molecular fields in drug discovery: getting old or reaching maturity?","volume":"15","author":"Cross","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1749-6632.2002.tb04185.x","article-title":"The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors","volume":"965","author":"Cumming","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0969-8051(02)00448-1","article-title":"Kinetics of the uptake and distribution of the dopamine D(2,3) agonist (R)-N-[1-(11)C]n-propylnorapomorphine in brain of healthy and MPTP-treated G\u00f6ttingen miniature pigs","volume":"30","author":"Cumming","year":"2003","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0095","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/ar800237f","article-title":"Responsive MRI agents for sensing metabolism in vivo","volume":"42","author":"De Leon-Rodriguez","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuroimage.2005.09.052","article-title":"Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy","volume":"30","author":"Derry","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuroimage.2009.11.077","article-title":"Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study","volume":"50","author":"Egerton","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0110","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2174\/092986706777935258","article-title":"PET tracers for imaging of the dopaminergic system","volume":"13","author":"Elsinga","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-2952(90)90642-X","article-title":"Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins","volume":"39","author":"Emerit","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1755-5949.2007.00033.x","article-title":"PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter","volume":"14","author":"Emond","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tins.2011.05.005","article-title":"Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia","volume":"34","author":"Ewers","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0130","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2174\/156802610793176837","article-title":"Current state of agonist radioligands for imaging of brain dopamine D2\/D3 receptors in vivo with positron emission tomography","volume":"10","author":"Finnema","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0135","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","article-title":"18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease","volume":"134","author":"Fodero-Tavoletti","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1021\/ar960068c","article-title":"Working against time: rapid radiotracer synthesis and imaging the human brain","volume":"30","author":"Fowler","year":"1997","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2004.06.002","article-title":"Importance of P-glycoprotein at blood-tissue barriers","volume":"25","author":"Fromm","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11307-005-0932-0","article-title":"Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism","volume":"7","author":"Ginovart","year":"2005","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0155","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0160","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","article-title":"Role of microglia in CNS inflammation","volume":"585","author":"Graeber","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hbm.20392","article-title":"Brain region binding of the D2\/3 agonist [11C]-(+)-PHNO and the D2\/3 antagonist [11C]raclopride in healthy humans","volume":"29","author":"Graff-Guerrero","year":"2008","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0170","first-page":"302","article-title":"Brain receptor imaging","volume":"47","author":"Heiss","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0175","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1586\/ern.10.136","article-title":"Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease","volume":"10","author":"Herholz","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1474-4422(11)70123-5","article-title":"Clinical amyloid imaging in Alzheimer's disease","volume":"10","author":"Herholz","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cpet.2010.02.004","article-title":"PET in brain tumors","volume":"5","author":"Hustinx","year":"2010","journal-title":"PET Clin."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0190","first-page":"1531","article-title":"Quantitative analysis of 11C-verapamil transfer at the human blood\u2013brain barrier for evaluation of P-glycoprotein function","volume":"47","author":"Ikoma","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0195","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jama.293.7.855","article-title":"Molecular imaging in the clinical arena","volume":"293","author":"Jaffer","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0200","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1148\/radiol.2443061756","article-title":"PET\/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet","volume":"244","author":"Judenhofer","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0205","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm1700","article-title":"Simultaneous PET-MRI: a new approach for functional and morphological imaging","volume":"14","author":"Judenhofer","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0210","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2967\/jnumed.110.077164","article-title":"Target-specific PET probes for neurodegenerative disorders related to dementia","volume":"51","author":"Kadir","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/clpt.2009.138","article-title":"Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications","volume":"86","author":"Kannan","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0893-133X(97)00069-9","article-title":"In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands","volume":"17","author":"Kegeles","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0225","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/brain\/awq091","article-title":"In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy","volume":"133","author":"Kikuchi","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0230","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.ne.15.030192.000511","article-title":"Adrenergic receptors as models for G protein-coupled receptors","volume":"15","author":"Kobilka","year":"1992","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00004647-200405000-00007","article-title":"In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the \u201cceiling effect\u201d in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta","volume":"24","author":"Kortekaas","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0245","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2967\/jnumed.109.070151","article-title":"P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide","volume":"51","author":"Kreisl","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0250","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00259-006-0324-y","article-title":"Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl-11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates","volume":"34","author":"Kumar","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0255","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clineuro.2010.09.012","article-title":"Promising role of [18F] fluorocholine PET\/CT vs [18F] fluorodeoxyglucose PET\/CT in primary brain tumors\u2014early experience","volume":"113","author":"Lam","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2010.06.002","article-title":"Small-animal positron emission tomography as a tool for neuropharmacology","volume":"31","author":"Lancelot","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0265","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review","volume":"20","author":"Laruelle","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0270","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1021\/jm800510m","article-title":"Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function","volume":"51","author":"Lazarova","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0275","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1023\/B:PHAM.0000036905.82914.8e","article-title":"Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders","volume":"21","author":"Lee","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0280","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00259-009-1274-y","article-title":"[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging","volume":"37","author":"Lemoine","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2967\/jnumed.109.066811","article-title":"Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes","volume":"51","author":"Ma","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0290","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1750-3639.2007.00067.x","article-title":"Inflammatory cell migration into the central nervous system: a few new twists on an old tale","volume":"17","author":"Man","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0295","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1002\/anie.200800222","article-title":"Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography","volume":"47","author":"Miller","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0300","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0006-8993(92)91100-S","article-title":"Further evidence for differential affinity states of the serotonin 1A receptor in rat hippocampus","volume":"590","author":"Mongeau","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0305","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/syn.20566","article-title":"Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature","volume":"62","author":"Narendez","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0310","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1046\/j.1471-4159.1994.62051822.x","article-title":"Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin","volume":"62","author":"N\u00e9non\u00e9n\u00e9","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/npy.11.12","article-title":"Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders","volume":"1","author":"Newmann-Tancredi","year":"2011","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0320","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/jcbfm.2010.104","article-title":"Measuring endogenous 5-HT release by emission tomography: promises and pitfalls","volume":"30","author":"Paterson","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0325","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.20528","article-title":"Activity-dependent regulation of energy metabolism by astrocytes: an update","volume":"55","author":"Pellerin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0330","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/CCO.0b013e32834aa752","article-title":"Advances in PET imaging of brain tumors: a referring physician's perspective","volume":"23","author":"Petrirena","year":"2011","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0335","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0340","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.2860723","article-title":"Positron emission tomography: human brain function and biochemistry","volume":"228","author":"Phelps","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0345","first-page":"639","article-title":"Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET\/MRI","volume":"47","author":"Pichler","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0350","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2967\/jnumed.109.061853","article-title":"PET\/MRI: paving the way for the next generation of clinical multimodality imaging applications","volume":"51","author":"Pichler","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6446(04)03334-3","article-title":"Using imaging biomarkers to accelerate drug development and clinical trials","volume":"10","author":"Pien","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0360","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","article-title":"PET radiotracers: crossing the blood\u2013brain barrier and surviving metabolism","volume":"30","author":"Pike","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0365","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson disease","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0370","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1741-8372(04)02429-6","article-title":"The targetable G protein proteome: where is the next generation of drug targets?","volume":"3","author":"Rebois","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0375","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/nimg.1997.0300","article-title":"Characterizing the relationship between BOLD contrast and regional cerebral blood flow measurements by varying the stimulus presentation rate","volume":"6","author":"Rees","year":"1997","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0380","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2310\/7290.2011.00003","article-title":"Techniques for molecular imaging probe design","volume":"10","author":"Reynolds","year":"2011","journal-title":"Mol. Imaging."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0385","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1523\/JNEUROSCI.21-21-08378.2001","article-title":"Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors)","volume":"21","author":"Riad","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0390","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1523\/JNEUROSCI.0950-04.2004","article-title":"Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat","volume":"24","author":"Riad","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0395","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awn054","article-title":"Cognitive deficits and striato-frontal dopamine release in Parkinson's disease","volume":"131","author":"Sawamoto","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0400","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2967\/jnumed.110.086629","article-title":"The translocator protein","volume":"52","author":"Scarf","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0405","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14737175.7.1.75","article-title":"Regulators of G-protein-coupled receptor-G-protein coupling: antidepressants mechanism of action","volume":"7","author":"Schreiber","year":"2007","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0410","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.54.5.1042","article-title":"Transplantation of embryonic porcine mesencephalic tissue in patients with PD","volume":"54","author":"Schumacher","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0415","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.drudis.2010.08.012","article-title":"PET tracers for the peripheral benzodiazepine receptor and uses thereof","volume":"21\u201322","author":"Schweitzer","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0420","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/anie.199422581","article-title":"Technetium radiopharmaceuticals\u2014fundamentals, synthesis, structure, and development","volume":"33","author":"Schwochau","year":"1994","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0425","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/syn.890030113","article-title":"Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain","volume":"3","author":"Seeman","year":"1989","journal-title":"Synapse"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0430","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/jcbfm.2010.173","article-title":"Striatal and cortical BOLD, blood flow, blood volume, oxygen consumption, and glucose consumption changes in noxious forepaw electrical stimulation","volume":"31","author":"Shih","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0435","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.biopsych.2007.11.016","article-title":"Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers","volume":"63","author":"Sibon","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0440","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","article-title":"The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat","volume":"28","author":"Sokoloff","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0445","first-page":"623","article-title":"The applications of PET in clinical oncology","volume":"32","author":"Strauss","year":"1991","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0450","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn2977","article-title":"The role of G protein-coupled receptors in the pathology of Alzheimer's disease","volume":"12","author":"Thathiah","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0455","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2217\/iim.09.22","article-title":"How have developments in molecular imaging techniques furthered schizophrenia research?","volume":"1","author":"Thompson","year":"2009","journal-title":"Imaging Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0460","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/syn.20845","article-title":"Differential effects of stress on [\u00b9\u00b9C]raclopride and [\u00b9\u00b9C]MNPA binding to striatal D\u2082\/D\u2083 dopamine receptors: a PET study in conscious monkeys","volume":"65","author":"Tsukada","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0465","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/syn.10134","article-title":"5-HT(1A) receptor imaging in the human brain: effect of tryptophan depletion and infusion on [(18)F]MPPF binding","volume":"46","author":"Udo de Haes","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0470","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drudis.2009.11.004","article-title":"From biomarker strategies to biomarker activities and back","volume":"15","author":"van Gool","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0475","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pneurobio.2006.10.002","article-title":"The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging","volume":"80","author":"Venneti","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0480","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s00259-008-0853-7","article-title":"Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU","volume":"35","author":"Verbruggen","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0485","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1010654108","article-title":"Addiction: beyond dopamine reward circuitry","volume":"108","author":"Volkow","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0490","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.addr.2010.09.011","article-title":"Approaches using molecular imaging technology\u2014use of PET in clinical microdose studies","volume":"63","author":"Wagner","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0495","first-page":"205","article-title":"Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-l-tyrosine for tumor imaging","volume":"40","author":"Wester","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0500","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.npp.1301400","article-title":"First human evidence of d-amphetamine induced displacement of a D2\/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study","volume":"33","author":"Willeit","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0505","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002093-200304000-00002","article-title":"The magnitude of dementia occurrence in the world","volume":"17","author":"Wimo","year":"2003","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0510","doi-asserted-by":"crossref","unstructured":"Zimmer, L., Descarries, L., in press. Internalization of serotonin 5-HT1a autoreceptors as an imaging biomarker of antidepressant response. WIREs Memb. Transp. Signal.","DOI":"10.1002\/wmts.11"},{"key":"10.1016\/j.neuroimage.2011.12.037_bb0515","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.neuroimage.2004.03.020","article-title":"Toward brain imaging of serotonin 5-HT1A autoreceptor internalization","volume":"22","author":"Zimmer","year":"2004","journal-title":"NeuroImage"}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105381191101439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105381191101439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T16:45:42Z","timestamp":1561135542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105381191101439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S105381191101439X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroimage.2011.12.037","relation":{},"ISSN":["1053-8119"],"issn-type":[{"value":"1053-8119","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}